Skip to main content

Table 1 Current tenofovir PREP Studies

From: Media reporting of tenofovir trials in Cambodia and Cameroon

Study Location Population Group Sponsor Study Goal Expected Initial Results
Cambodia Commercial sex workers 960 volunteers NIH Safety & efficacy 2007
Cameroon, Ghana High-risk women 800 volunteers FHI Safety & efficacy 2007
Malawi High-risk men 500 volunteers FHI Safety & efficacy 2007
Botswana Young adults 1,200 volunteers CDC Safety &efficacy 2007
Thailand Injection drug users 1,600 volunteers CDC Safety & efficacy 2007
United States Men who have sex with men CDC Safety 2007
Peru Men who have sex with men 2,100 volunteers NIH Safety & efficacy 2008